Katharine Peterson, Chief Accounting Officer at Acrivon Therapeutics, Inc. (ACRV), sold 101 shares at $2.01 ($203) on 2026-08-18, disclosed to the SEC on 2026-08-20.
Open-market sale of $203 ACRV by Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.